Global Dermatology Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

SKU ID : GIR-GIR1901240137 13083878

Publishing Date : 13-Feb-2019

No. of pages : 122

PRICE
3480
6960


  • Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.

    Scope of the Report:
    The classification of Dermatology Drug includes External Use, Oral and Injection, and the revenue proportion of External Use in 2015 is about 73.74%.
    Dermatology Drug is widely used for Psoriasis, Skin Infections, Acne, Dermatitis and other skin diseases. Amongst these different types of skin diseases, Psoriasis was the largest revenue generating segment in 2015, and the revenue market share is about 48.04%.
    The worldwide market for Dermatology Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
    This report focuses on the Dermatology Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

    Market Segment by Manufacturers, this report covers
    AbbVie
    Johnson & Johnson
    Bayer
    Galderma
    Bristol-Myers Squibb
    Novartis
    Pfizer
    Merz Pharma
    Valeant
    LEO Pharma
    GlaxoSmithKline

    Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    External Use
    Oral
    Injection

    Market Segment by Applications, can be divided into
    Psoriasis
    Skin Infections
    Acne
    Dermatitis
    Other

    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Dermatology Drug product scope, market overview, market opportunities, market driving force and market risks.
    Chapter 2, to profile the top manufacturers of Dermatology Drug, with price, sales, revenue and global market share of Dermatology Drug in 2017 and 2018.
    Chapter 3, the Dermatology Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Dermatology Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
    Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
    Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
    Chapter 12, Dermatology Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
    Chapter 13, 14 and 15, to describe Dermatology Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.